Effects of toxins on Ca2+ currents and peptide release from nerve terminals.
Lemos
J R
JR
Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts 01545.
Wang
G
G
Wang
X
X
Stuenkel
E L
EL
Nordmann
J J
JJ
Treistman
S N
SN
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D044182:Benzylisoquinolines; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D015220:Calcium Channels / Q000187:drug effects / Q000502:physiology*; D005089:Exocytosis / Q000187:drug effects*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D008978:Mollusk Venoms / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects / Q000502:physiology*; D010121:Oxytocin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010904:Pituitary Gland, Posterior / Q000187:drug effects / Q000502:physiology*; D011073:Polyamines / Q000494:pharmacology; D051381:Rats; D014688:Venoms / Q000494:pharmacology*
D000470:Alkaloids; D044182:Benzylisoquinolines; D002121:Calcium Channel Blockers; D015220:Calcium Channels; C071920:FTX, spider toxin; D008978:Mollusk Venoms; D011073:Polyamines; D014688:Venoms; D001127:Arginine Vasopressin; C009438:tetrandrine; D010121:Oxytocin